v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 13,381 $ 11,777
Cost of revenue 6,499 6,236
Gross profit 6,882 5,541
Operating expenses:    
Research and development 3,471 3,829
Selling, general and administrative 9,914 10,239
Change in fair value of contingent consideration 6,381 2,499
Total operating expenses 19,766 16,567
Loss from continuing operations (12,884) (11,026)
Other income, net:    
Interest income 936 816
Income from transition services agreement, net   406
Other expense, net (7) (33)
Total other income, net 929 1,189
Net loss from continuing operations (11,955) (9,837)
Net income (loss) from discontinued operations, net of tax   53,440
Net income (loss) attributable to common stockholders $ (11,955) $ 43,603
Net loss from continuing operations per share attributable to common stockholders, basic $ (0.32) $ (0.28)
Net loss from continuing operations per share attributable to common stockholders, diluted (0.32) (0.28)
Net income (loss) from discontinued operations per share attributable to common stockholders, basic   1.51
Net income (loss) from discontinued operations per share attributable to common stockholders, diluted 0.00 1.51
Net income (loss) per share attributable to common stockholders, basic (0.32) 1.23
Net income (loss) per share attributable to common stockholders, diluted $ (0.32) $ 1.23
Weighted average common shares outstanding, basic 36,818,652 35,386,483
Weighted average common shares outstanding, diluted 36,818,652 35,386,483
Product revenue    
Revenue $ 10,737 $ 8,529
Cost of revenue 5,160 4,725
Service and contract revenue    
Revenue 2,644 3,248
Cost of revenue $ 1,339 $ 1,511